The global amniotic membrane market is estimated to hold a value of US$ 11.12 Bn in 2032 and is expected to expand at a CAGR of 14% during the forecast period from 2022 to 2032. Growth in the market can be attributed to the increasing cases of accidents and the rising awareness about the benefits offered provided by the amniotic membrane.
The advantages offered by the amniotic membranes, such as; their ability to reduce pain, can lead to the growing adoption of tissue-based products to heal surgical wounds. Furthermore, increasing expenditure in R&D in regenerative medicine and stem cells is expected to augment the market size in the forecast period.
The outbreak of COVID-19 brought a negative impact on the market owing to the disruptions caused in the supply chain. Temporary halt in supply and manufacturing affected the market by restraining revenue generation. However, the key players are taking various initiatives to counter the challenges posed by the COVID-19 lockdown.
Download Sample Copy of This Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=7125
Key Takeaways from the Market Study
- The global amniotic membrane market to value about USD 3 Bn in 2022
- North America to accumulate a revenue share of about 30% for amniotic membranes in 2032
- Europe to experience noteworthy growth, accelerating at a CAGR of 10% through 2032
- By application, surgical wounds to comprise 36% of the global market revenue
- Hospitals to be primary end users, expected to account for nearly 2/5th of the global market share
Competitive Landscape
The global players of the amniotic membrane market adopt various strategies to enhance their global reach and secure the forefront position in the market. Partnership, acquisitions, and collaboration are some of the most adopted approaches to expand their market footprint. Some of the recent developments among the key players are:
- In July 2022, Merakris Therapeutics launched Dermacyte Matrix. It is an amniotic membrane used for the protection and repair of damaged tissues.
- In February 2022, TissueTech, a renowned name in the clinical application of cryopreserved human birth tissue products to treat chronic wounds, ocular surface disorders, and musculoskeletal conditions, disclosed its new name and a new logo. BioTissue, Inc and Amniox Medical, Inc. will both be known under a single entity called, BioTissue, Inc.
- In December 2021, Audax Private Equity disclosed that it had successfully completed the sale of Katena Products to Corza Medical. Corza Medical is a GTCR portfolio company. Katena is a renowned entity offering ophthalmic devices and therapeutics to hospitals, surgical centers, and clinics.
Get Customization on this Report for Specific Research Solutions –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7125
Key Companies Profiled
- Alliqua BioMedical Inc.
- Amnio Technology LLC
- Applied Biologics LLC
- Human Regenerative Technologies LLC
- DermaSciences
- Katena Products Inc.
- MiMedx Group Inc.
- Skye Biologics Inc.
- Amniox Medical Inc.
- Integra LifeSciences Corporation
Key Market Segments Covered in the Global Amniotic Membrane Market
- By Product
- Cryopreserved Amniotic Membrane
- Dehydrated Amniotic Membrane
- By Application
- Amniotic Membrane for Surgical Wounds
- Amniotic Membrane for Ophthalmology
- Amniotic Membrane for Other Applications
- By End Use
- Amniotic Membrane for Hospitals
- Amniotic Membrane for Ambulatory Surgical Centers
- Amniotic Membrane for Specialty Clinics
- Amniotic Membrane for Academic & Research Institutes
Get Full Access of Complete Report –
https://www.factmr.com/checkout/7125
Questionnaire answered in the Amniotic Membrane Market report include:
- How the market for Amniotic Membrane has grown?
- What is the present and future outlook of the global Amniotic Membrane on the basis of region?
- What are the challenges and opportunities for the Amniotic Membrane?
- Why the consumption of Amniotic Membrane highest in region?
- In which year segment is expected to overtake segment?
Explore Fact.MR’s More Insights on the Healthcare Domain
Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html
ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract–glaucoma-treatment-factmr-301262063.html
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: [email protected]
Contact Information:
+1 (628) 251-1583
Tags:
Reportedtimes, Financial Content, Extended Distribution, Research Newswire, English
Contact Information:
+1 (628) 251-1583
Add Comment